Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
Academy, acid, administered, affirmative, American, antisense, Brazil, CT, damage, defense, DMD, domain, EVP, exon, expression, fewer, Hawaiian, Hurler, Inborn, medicine, Metabolism, microdystrophin, Ophthalmology, Pakola, pharmacodynamic, preliminary, promising, promoter, recently, regenerative, Regulation, resistance, restore, ribonucleic, RMAT, shift, skipping, Society, stage, Stephen, steroid, sustained, Symposium, syndrome, trading, transgene, World
Removed:
adaptive, behavior, biomarker, BLA, body, breathing, buildup, cardiomyopathy, cell, cognitive, continued, CSF, daily, death, degenerate, delivered, eventually, expand, expanded, fluid, function, importance, independence, movement, NAb, neurodevelopmental, neutralizing, partnered, pediatric, premature, prevent, procedure, reduce, separate, surrogate, weak
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view